ghk-cu jupiter (Copper Peptide) Therapy GHK-Cu – True Research Labs

Not for human consumption or therapeutic use

Food and Drug Administration approved revised COVID-19 vaccines for seniors 65 and older as well as younger adults and children with at least one underlying condition that increases their risk for severe infection, including asthma, obesity and lung disease

Animal doses cannot be directly extrapolated to humans Key Research Findings# Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice , published in Biochemical Pharmacology (Neelakantan H et al., 2018

Peptide clearance does not scale identically across species, and the animal work used anesthetized preparations and doses far above the human protocol

The main precautionary note for GHK-Cu concerns individuals with known copper metabolism disorders or Wilsons disease, for whom any additional copper loading, including from GHK-Cu, would be contraindicated

Muscle relaxants address the spasm component but do not treat the underlying disc pathology